U.S. halts distribution of Eli Lilly’s coronavirus antibody treatment bamlanivimab as a monotherapy

The U.S. government has halted distribution of Eli Lilly’s COVID-19 antibody treatment bamlanivimab (LY-CoV555) as a monotherapy just four months after it received FDA emergency use authorization, citing a sustained increase in variants of SARS-CoV-2 that are resistant to the monotherapy.  More...

More than 60 animals confirmed with Sars-Cov-2 infection

Of the more than 60 animals confirmed with SARS-CoV-2 infection in a study of more than 450 animals living in the Brazos County area Texas A&M study, less than a quarter were reported to show signs of disease around the time of the owner’s diagnosis, most commonly including sneezing, coughing, diarrhea, or being less active than normal.  More...

70% of patients hospitalised with coronavirus haven’t fully recovered five months later

The majority of survivors who left hospital following COVID-19 did not fully recover five months after discharge and continued to experience negative impacts on their physical and mental health, as well as ability to work, according to results released by the PHOSP-COVID study today.  More...